1. Home
  2. VYGR vs SPIR Comparison

VYGR vs SPIR Comparison

Compare VYGR & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • SPIR
  • Stock Information
  • Founded
  • VYGR 2013
  • SPIR 2012
  • Country
  • VYGR United States
  • SPIR United States
  • Employees
  • VYGR N/A
  • SPIR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • SPIR Telecommunications Equipment
  • Sector
  • VYGR Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • VYGR 342.5M
  • SPIR 328.5M
  • IPO Year
  • VYGR 2015
  • SPIR N/A
  • Fundamental
  • Price
  • VYGR $5.75
  • SPIR $13.25
  • Analyst Decision
  • VYGR Strong Buy
  • SPIR Strong Buy
  • Analyst Count
  • VYGR 9
  • SPIR 6
  • Target Price
  • VYGR $16.44
  • SPIR $19.20
  • AVG Volume (30 Days)
  • VYGR 485.6K
  • SPIR 287.0K
  • Earning Date
  • VYGR 11-12-2024
  • SPIR 12-31-2024
  • Dividend Yield
  • VYGR N/A
  • SPIR N/A
  • EPS Growth
  • VYGR N/A
  • SPIR N/A
  • EPS
  • VYGR 0.47
  • SPIR N/A
  • Revenue
  • VYGR $163,784,000.00
  • SPIR $107,223,000.00
  • Revenue This Year
  • VYGR N/A
  • SPIR $18.02
  • Revenue Next Year
  • VYGR N/A
  • SPIR $13.78
  • P/E Ratio
  • VYGR $12.33
  • SPIR N/A
  • Revenue Growth
  • VYGR 3.40
  • SPIR 24.15
  • 52 Week Low
  • VYGR $5.19
  • SPIR $6.26
  • 52 Week High
  • VYGR $11.72
  • SPIR $19.40
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 41.30
  • SPIR 47.14
  • Support Level
  • VYGR $6.08
  • SPIR $12.38
  • Resistance Level
  • VYGR $6.55
  • SPIR $14.29
  • Average True Range (ATR)
  • VYGR 0.35
  • SPIR 0.84
  • MACD
  • VYGR -0.05
  • SPIR -0.38
  • Stochastic Oscillator
  • VYGR 14.51
  • SPIR 27.97

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: